Central Drugs Standard Control Organisation
Make WHO-recommended new COVID-19 drugs accessible, affordable, demands MSF

US pharma giant Eli Lilly has the patent for Baricitinib, which will affect its availability and accessibility. MSF has called on governments to take immediate steps to ensure that patent monopolies do not stand in the way of access to this drug

    × To Subscribe